跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50
Authorized
STANDARD
HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b5868f6208e23441
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
b5868f6208e23441
Drug Approval Canada Name
HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50
Product Name
HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50
Status
Marketed
Status Date
2018-08-21
Original Market Date
2018-08-21
Din
02469413
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular , Subcutaneous , Intravenous
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N02AA03 HYDROMORPHONE
Atc Name
n 02 aa 03
Aig Number
0108698008
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
HYDROMORPHONE HYDROCHLORIDE
50 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b5868f6208e23441
Type
Standard
Back to Health Canada Approvals
